AIDSmeds.com - CROI 2007 : The Skinny on Metabolic Complications

POZ.com | POZ Mentor
POZ Personals

» »

14th Conference on Retroviruses and Opportunistic Infections
Los Angeles, California
February 25-28, 2007

Starting and Switching Treatment | Experimental HIV Drugs
HIV/AIDS Complications and Treatment Side Effects
HIV Transmission and Prevention | Expert Interviews | Diary of a Doc

The Skinny on Metabolic Complications

March 8, 2007

Don Kotler
AIDSmeds founder Peter Staley interviewed Dr. Donald Kotler, chief of gastroenterology at St. Luke's-Roosevelt Hospital in New York, and a longtime researcher of wasting, lipodystrophy, and metabolic problems in people with HIV. Kotler discusses TH-9507, an experimental drug for reducing fat around the gut; Fosamax helping with bone loss in HIVers; high-fat diets in people with HIV; and whether lipid-lowering drugs work well for HIVers.

Double click for the full interview (21 minutes):

Or hear part I about TH-9507, an experimental drug for reducing fat around the gut (8 minutes):

Or hear part II about Fosamax helping with bone loss in HIVers (6 minutes):

Or hear part III about high-fat diets in people with HIV (2 minutes):

Or hear part IV about whether lipid-lowering drugs work well for HIVers (5 minutes):

Or click here to read the full transcript of the interview.

Our post-CROI conference interviews were generously sponsored by Abbott Laboratories.

Starting and Switching Treatment

March 9, 2007
		Study Finds Viread Advantages in Black Patients

March 6, 2007
		Twice-Daily Kaletra Possibly Better for Some Patients

March 1, 2007
		Once-Daily Viramune Strikes Out

		Fewer Side Effects with Videx/Epivir vs. Combivir

		Still No Clear Benefit of Treating Early HIV (Reuters Health)

February 26, 2007
		One in 10 Infected with Drug-Resistant HIV

Experimental HIV Drugs

March 2, 2007
		Non-Nuke TMC-278 Comparable to Sustiva

March 1, 2007
		Integrase Inhibitor Elvitegravir (GS-9137) Shows Well

February 28, 2007
		Isentress (MK-0518) Results Prove Promising

		Encouraging Data from Two Maraviroc Studies

HIV/AIDS Complications and Treatment Side Effects

March 5, 2007
		Baraclude Induces HIV Drug Resistance

March 2, 2007
		HIV+ Less Responsive to Lipid-Lowering Meds

		Study Says Less Fat for Lower Lipids

February 28, 2007
		Shift in Cancer-Related Deaths in HIV

February 27, 2007
		TH9507 Shows Promise for Lipodystrophy

February 26, 2007
		More Lipoatrophy with Sustiva vs. Kaletra

		Zetia Lowers 'Bad' LDL Cholesterol

		Fosamax, Calcium, and Vitamin D for Bone Weakness

HIV Transmission and Prevention

February 27, 2007
		Breastfeeding Safer for Some HIV+ Mothers (Reuters Health)

Expert Interviews

March 9, 2007
		The Plot Thickens: HIV Treatment Challenges

March 8, 2007
		The Skinny on Metabolic Complications

		What's New? Update on Experimental Agents

Diary of a Doc

March 13, 2007
		Diary of a Doc: On the Origins of HIV

March 2, 2007
		Diary of a Doc: New Strategies for HIV-Herpes Coinfection